Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ANAB - AnaptysBio, Inc.
145 M
LAST VALUE
93.07%
2 YEAR CAGR
24.71%
5 YEAR CAGR
128.70%
10 YEAR CAGR